Big Pharma's Hidden Business Model and How Your Company Funds It
Harvard Business Review
SEPTEMBER 12, 2012
The study assembles considerable evidence about the hidden business model of major pharmaceutical companies: to devote most of their research budget to developing hundreds of drugs that provide few if any advantages over existing drugs and then market them heavily to doctors and patients. At Harvard's Edmond J.
Let's personalize your content